Boston Scientific (BSX) Other Accumulated Expenses (2009 - 2026)
Boston Scientific (BSX) posted quarterly Other Accumulated Expenses of $732.0 million for Q2 2026, down 23.11% year-over-year from $952.0 million in Q2 2025, and down 16.34% on a QoQ basis from $875.0 million in Q1 2026.
Boston Scientific (BSX) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
Boston Scientific has reported Other Accumulated Expenses for 18 years, with the latest figure at $732.0 million in Q2 2026.
- Other Accumulated Expenses for Q2 2026 came in at $732.0 million, down 23.11% year-over-year; the trailing twelve-month figure through Jun 2026 was $732.0 million (down 23.11% YoY), and the FY2025 annual result was $795.0 million, down 10.37% from the prior year.
- Other Accumulated Expenses declined to $732.0 million in Q2 2026, from $875.0 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $1.0 billion in Q1 2022 and troughed at $732.0 million in Q2 2026.
- A 5-year average of $848.2 million and a median of $844.5 million in 2024 frame the typical range for Other Accumulated Expenses.
- The widest annual swing landed in 2022, when Other Accumulated Expenses soared 46.67%; it then declined 23.89% in 2023.
- A 5-year view of Other Accumulated Expenses shows it stood at $761.0 million in 2022, then climbed by 6.96% to $814.0 million in 2023, then grew by 8.97% to $887.0 million in 2024, then slipped by 10.37% to $795.0 million in 2025, then fell by 7.92% to $732.0 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $732.0 million in Q2 2026, $875.0 million in Q1 2026, and $795.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 732.00 Mn |
| Mar 31, 2026 | 875.00 Mn |
| Dec 31, 2025 | 795.00 Mn |
| Sep 30, 2025 | 862.00 Mn |
| Jun 30, 2025 | 952.00 Mn |
| Mar 31, 2025 | 923.00 Mn |
| Dec 31, 2024 | 887.00 Mn |
| Sep 30, 2024 | 891.00 Mn |
| Jun 30, 2024 | 770.00 Mn |
| Mar 31, 2024 | 827.00 Mn |
| Dec 31, 2023 | 814.00 Mn |
| Sep 30, 2023 | 882.00 Mn |
| Jun 30, 2023 | 940.00 Mn |
| Mar 31, 2023 | 787.00 Mn |
| Dec 31, 2022 | 761.00 Mn |
| Sep 30, 2022 | 752.00 Mn |
| Jun 30, 2022 | 784.00 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 783.00 Mn |
| Sep 30, 2021 | 669.00 Mn |